Geriatric medicines, additionally called geriatrics is a division of medicines related with preventive, healing, clinical and social parts of illness for the most part among individuals that are matured more than 65 years or more. Without appropriate consideration, a maturing body perpetually loses invulnerability and geriatrics are exceedingly inclined to neurological, cardiovascular, and respiratory sicknesses, among others. Geriatric drugs are a forte part of therapeutic science that gives modified diagnostics and treatment choices for the elderly, and the market for the equivalent is thriving.
How Big is The Geriatric Medicine Market?
The Geriatric Medicine Market is expected to be around US$ 184254 Million by 2028 at a CAGR of 7% in the given forecast period.
The major driving factors of Geriatric Medicine Market are as follows:
The major restraining factors of Geriatric Medicine Market are as follows:
The major opportunities of Geriatric Medicine Market are as follows:
The Geriatric Medicine Market has been segmented as below:
By Product:
By Application:
The Geriatric Medicine Market is segmented on the lines of its product, application and regional. On the basis of product, it is segmented into Analgesics, Antihypertensives, Statins, Antidiabetics, Proton Pump Inhibitor, Anticoagulant, Antipsychotic, Antidepressant. Based on application classification it covers Cardiovascular, Arthritis, Neurological, Cancer, Osteoporosis and Respiratory. The Geriatric Medicine Market on geographic segmentation covers various regions such as North America, Europe, Asia Pacific, and Rest of World. Each geographic market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.
This report provides:
1) An overview of the global market for Geriatric Medicine Market and related technologies.
2) Analyses of global market trends, with data from 2021, estimates for 2022 and 2023, and projections of compound annual growth rates (CAGRs) through 2028.
3) Identifications of new market opportunities and targeted promotional plans for Geriatric Medicine Market.
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.
Report Scope:
The scope of the report includes a detailed study of Geriatric Medicine Market with the reasons given for variations in the growth of the industry in certain regions.
The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include GSK, Boehringer Ingelheim, Novartis, Bristol-Myers Squibb, Pfizer, Eli Lilly, Abbott, AstraZeneca, Merck, Sanofi S.A. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.
The Top Companies Report is intended to provide our buyers with a snapshot of the industry’s most influential players.
Reasons to Buy this Report:
Customization:
We can offer you custom research reports as per client’s special requirements.
Below are our New Reports :-
1. Introduction
1.1 Report Description
1.2 Markets Covered
1.3 Stakeholders
2. Research Methodology
2.1 Research Data
2.2 Market Size Estimation and Data Triangulation
2.3 Research Assumptions
3. Report Summary
4. Market Overview
4.1 Introduction
4.2 Drivers
4.3 Restrains
4.4 Industry Trends
4.5 Porter’s Five Forces Analysis
5. Geriatric Medicine Market Analysis, By Product
5.1 Analgesics
5.2 Antihypertensives
5.3 Statins
5.4 Antidiabetics
5.5 Proton Pump Inhibitor
5.6 Anticoagulant
5.7 Antipsychotic
5.8 Antidepressant
6. Geriatric Medicine Market Analysis, By Application
6.1 Cardiovascular
6.2 Arthritis
6.3 Neurological
6.4 Cancer
6.5 Osteoporosis
6.6 Respiratory
7. Geriatric Medicine Market Analysis, By Region
7.1 North America
7.2 Europe
7.3 Asia-Pacific
7.4 Rest of the World
8. Competitive Overview
8.1 Introduction
8.2 New Product Launches
8.3 Acquisitions
8.4 Agreements, Partnerships, And Collaborations
8.5 Expansions
9. Company Profiles
9.1 GSK
9.2 Boehringer Ingelheim
9.3 AstraZeneca
9.4 Merck
9.5 Bristol-Myers Squibb
9.6 Novartis
9.7 Eli Lilly
9.8 Abbott
9.9 Pfizer
9.10 Sanofi S.A.
The Geriatric Medicine Market has been segmented as below:
By Product:
By Application:
By Regional Analysis:
